WeVote
Log In

Bill

Bill

HB 6090

AN ACT CONCERNING MEDICAID COVERAGE FOR PAN-ETHNIC SCREENING FOR PATIENTS WHO ARE PREGNANT OR PLANNING A PREGNANCY.

2025 Regular Session Introduced by Liz Linehan

Connecticut Medicaid would cover pan-ethnic genetic carrier screening for pregnant patients and those planning pregnancy, expanding access to hereditary condition testing.

REF. TO JOINT COMM. ON Human Services
#medicaid #medicaltests #pregnancy
0
WeVote Research Nonpartisan
Bill Summary · HB 6090

Legislative bill overview

HB 6090 would require Connecticut's Medicaid program to cover pan-ethnic carrier screening for patients who are pregnant or planning a pregnancy. Carrier screening tests identify whether individuals carry genes for certain inherited genetic conditions, allowing prospective parents to make informed reproductive decisions. This expands current coverage to include testing for conditions affecting various ethnic populations, not just those traditionally associated with specific groups.

Why is this important

Genetic carrier screening can help identify pregnancies at risk for serious inherited conditions like cystic fibrosis, sickle cell disease, and Tay-Sachs disease, enabling early intervention or informed family planning. Expanding Medicaid coverage removes financial barriers for low-income pregnant patients and those planning pregnancies, potentially reducing health disparities. The "pan-ethnic" approach recognizes that genetic conditions once thought specific to certain populations occur across all ethnic groups.

Potential points of contention

  • Cost implications: Expanded genetic screening increases Medicaid expenditures, raising questions about budget impact and whether resources could be better allocated elsewhere in healthcare
  • Clinical utility debate: Medical professionals disagree on which conditions warrant screening and whether comprehensive pan-ethnic panels provide better outcomes than targeted screening based on individual risk factors
  • Equity versus access: While removing financial barriers, universal coverage may lead to screening of patients who don't want it or don't understand results, raising concerns about informed consent and psychological impact

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.